https://www.selleckchem.com/pr....oducts/mi-2-malt1-in
Encephalitis/meningitis brings a heavy disease burden, and the origin of disease remains unknown in 30-40% of patients. It is greatly significant that combinations of nucleic acid amplification and autoimmune antibody testing improves the diagnosis and treatment of encephalitis/meningitis. Moreover, though several diagnostic methods are in clinical use, a recognized and unified diagnosis and treatment process for encephalitis management remains unclear. IMPROVE is a multicenter, open label, randomized controlled clinical tr
Like
Comment
Share
